UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 24, 2016 (August 22, 2016) 

 

VIVEVE MEDICAL, INC.

 (Exact name of registrant as specified in its charter)

 

Delaware

 

1-11388

 

04-3153858

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

150 Commercial Street

Sunnyvale, California

 

94086

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (408) 530-1900

 

No change

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 5.07.  Submission of Matters to a Vote of Security Holders.

 

On August 22, 2016, Viveve Medical, Inc. (the “Company”) held its 2016 Annual Meeting of Stockholders (the “Meeting”).  At the Meeting, the Company’s stockholders voted to: (1) elect seven directors to the Company’s board of directors (the “Board”); (2) approve the Viveve Medical, Inc. Amended and Restated 2013 Stock Option and Incentive Plan (the “Plan”); (3) ratify the appointment of Burr Pilger Mayer, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016; and (4) approve the compensation of the named executive officers in a non-binding advisory vote.

 

The proposals were approved based on the voting results as follows:

 

Proposal 1: Elect Seven Directors to the Board.

 

Director

 

Votes For

   

Votes Withheld

   

Broker Non-Votes

 

Lori Bush

 

8,159,834

   

1,159

   

1,253,457

 

Daniel Janney

 

8,159,893

   

1,100

   

1,253,457

 

Debora Jorn

 

8,159,893

   

1,100

   

1,253,457

 

Arlene Morris

 

8,159,836

   

1,157

   

1,253,457

 

Jon Plexico

 

8,159,874

   

1,119

   

1,253,457

 

Patricia Scheller

 

8,159,837

   

1,156

   

1,253,457

 

Brigitte Smith

 

7,938,894

   

222,099

   

1,253,457

 


Proposal 2: Approve the Plan.

 

Votes For

Votes Against

Abstentions

Broker Non-Votes

7,747,470

411,766

1,757

1,253,457

 

Proposal 3: Ratify the appointment of Burr Pilger Mayer, Inc. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016.

 

Votes For

Votes Against

Abstentions

9,399,644

1,896

12,910

 

Proposal 4: Approve the compensation of the Company’s named executive officers in a non-binding advisory vote.

 

Votes For

Votes Against

Abstentions

Broker Non-Votes

8,151,903

6,931

2,159

1,253,457

 

 
 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

  

VIVEVE MEDICAL, INC.

  

 

 

 

  

  

  

  

Date: August 24, 2016

By:

/s/ Patricia Scheller

  

 

 

Name: Patricia Scheller

Title: Chief Executive Officer